Stribild

About this medicine

Originator: Stribild by GILEAD SCIENCES INC · Manufacturer: GILEAD SCIENCES Pharma. Indication & Dosage: STRIBILD (ELVITEGRAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE) is a prescription medication that is used with other Human Immunodeficiency Virus Type 1 (HIV-1) medicines to treat HIV-1 infection in adults and children who are 12 years or older and weigh at least 35 kg. It can be used by people who have never taken HIV medicines before, or by people who have taken HIV medicines for at least 6 months and have a low amount of HIV in their blood (less than 50 copies/mL). STRIBILD should not be used by people who have failed HIV treatment before. To prevent transmission, follow patient’s HIV medication regimen, use a barrier method during sex, and do not share personal items with blood or fluids. STRIBILD is Manufactured by Gilead Sciences pharma Ltd. in USA. ELVITEGRAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE has to take orally once daily with food Side Effects: The most common adverse reactions ELVITEGRAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE are: Diarrhea , Vomiting , Headache , Rash , Stomach area (abdominal) pain, Nausea . The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.